US-based Marathon Pharmaceuticals has introduced a new needle-free device ZiNGO (lidocaine hydrochloride monohydrate) powder intradermal injection system.
The device has been developed to deliver a topical local anesthetic to manage venous access pain.
With the push of a button, the hand-held device delivers a 0.5mg dose of powdered lidocaine particles into the skin through a helium-powered delivery system, numbing the site in one to three minutes.
Connecticut Children’s Medical Center Pain and Palliative Medicine division head William Zempsky said: "ZiNGO is the first easy-to-administer, fast-acting topical local anesthetic that could lead to a paradigm shift in the approach to venous access procedures in children."
Initially, the company plans to distribute the device to children’s hospitals, medical centers and community hospitals.
Marathon Pharmaceuticals vice-president Tom Larson said the company recognize the high demands on clinicians caring for patients.
"ZiNGO has an onset of action in as little as one to three minutes, enabling nurses to reduce pain at the needle insertion site easily and efficiently in the busy hospital setting," Larson added.
Image: Marathon has introduced new hand-held device ZiNGO. Photo: courtesy of Marathon Pharmaceuticals, LLC.